Guilandina bonduc
Guilandina bonduc · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Guilandina bonduc is a versatile medicinal plant whose therapeutic potential is derived from its seeds, leaves, and roots. Various preparations, including ethanol, dichloromethane root extracts, EtOAc extracts, and CBD decoctions, are utilized to harness its bioactive properties. The plant contains significant chemical compounds such as cardiac glycosides that contribute to its diverse biological activities. Research indicates it possesses potent anthelmintic, antidiabetic, antioxidant, and antipsoriatic effects. Furthermore, it shows promise in addressing complex conditions ranging from Alzheimer's disease and autoimmune diseases to infections caused by Escherichia coli and Enterobacter aerogenes.
- Synonyms
- Glycyrrhiza Aculeata · Guilandina Homblei · 14 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Seed · Leaf
Classification
Synonyms
Guilandina bonduc is a botanical subject known to be associated with several distinct scientific synonyms. It is frequently referred to in older literature as Bonduc canadense or under the name Caesalpinia bonduc. Taxonomists also recognize several specific varieties under the Caesalpinia bonducella umbrella. These include the variations known as Caesalpinia bonducella var. aequiaculeata and Caesalpinia bonducella var. elegans. Additionally, the plant is linked to the classification of Caesalpinia bonducella var. inaequiaculeata, highlighting its complex naming history.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Guilandina bonduc is a fascinating specimen that belongs to the vast kingdom Plantae. Within this biological realm, the species is categorized under the class Equisetopsida. It falls into the order Fabales, showcasing its evolutionary connection to a diverse group of flowering plants. Specifically, this plant is a member of the family Fabaceae, making it a relative of many well-known legumes. Finally, it is classified under the genus Guilandina, which defines its unique botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Guilandina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Guilandina bonduc exhibits a wide and diverse distribution throughout the African continent. Its presence is noted across East Tropical Africa, specifically within the territories of Kenya and Tanzania. The species also reaches into Northeast Tropical Africa, spanning the regions of Ethiopia and Somalia. Furthermore, its range extends westward to the Macaronesian islands, including Cape Verde. This broad geographical spread highlights the plant's adaptability to various tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Guilandina bonduc is a versatile plant that typically exhibits a shrub-like growth form. Due to its obligatory climbing habit, it relies on surrounding structures to ascend toward the light. Depending on its environment, the height of this species can vary significantly. While some specimens may only reach a minimum of 1 meter, others can grow to a modest 15 meters. In certain conditions, the plant can achieve a maximum height of 15 meters, showcasing its impressive developmental range.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Guilandina bonduc, also known as Caesalpinia bonduc, is a versatile medicinal plant recognized for its wide range of therapeutic properties. Research has demonstrated its significant anthelmintic activity, making it a valuable resource for treating digestive parasitosis. Additionally, the plant serves as an effective antidiabetic agent, utilizing phenolic compounds and flavonoids to help manage blood glucose levels. Its biological profile is further enhanced by strong antioxidant capabilities and proven antipsoriatic effects, particularly when using leaf extracts. Finally, the plant shows promising antiviral potential, positioning it as a significant candidate for the development of novel natural therapies.
Compounds
Guilandina bonduc, also known as Caesalpinia bonducella, demonstrates significant medicinal value through its diverse phytochemical profile. Recent screening of flora from the Melghat forest in India has highlighted its impressive antibacterial potential against various pathogens. Specifically, the plant exhibits notable efficacy when tested against bacteria such as Escherichia coli and Staphylococcus aureus. Phytochemical analysis further reveals that this species contains important bioactive compounds, including cardiac glycosides. These glycosides were identified within both the ethanol and methanol extracts of the plant, underscoring its complex chemical makeup.
Conditions
Guilandina bonduc, also known as Caesalpinia bonducella, serves as a medicinal resource for treating diabetes through its various phytochemical constituents. The plant's seed extract also shows therapeutic potential in treating Alzheimer's disease by inhibiting several key target proteins. In terms of anti-plasmodial activity, the plant demonstrates the ability to treat 3D7 strains of the malaria parasite. Furthermore, it is effective in treating Dd2 parasites, which are known for being chloroquine-resistant. These specific properties highlight the plant's capacity to treat Dd2 parasites and other life-threatening conditions.
Preparations
Guilandina bonduc is prepared as an EtOAc extract from seed kernels to isolate cassane furanoditerpenoids with antimalarial activity. The plant is also prepared as a decoction (CBD) to evaluate its potential antipsoriatic effects. Researchers have utilized a dichloromethane root extract of the species for the isolation of Norcaesalpin D. Furthermore, the plant is prepared as an ethanol extract to screen for its antibacterial potential. Finally, an ethanolic root extract of the plant has been used in oral toxicity studies to assess its safety and tolerability in Wistar rats.
Parts used
Guilandina bonduc, also known as Caesalpinia bonduc, is a medicinal plant of significant interest due to the various therapeutic properties found in its different components. Research indicates that the seeds of this species contain cassane-type diterpenoids which exhibit antimalarial and cytotoxic activities. Furthermore, the leaves have been traditionally utilized and scientifically studied for their potential antipsoriatic and antiproliferant effects. The roots are also highly valued, with extracts demonstrating notable antiplasmodial activity against resistant malaria strains. Because its seeds, leaves, and roots are all exploited for medicinal use, the species is recognized as a vulnerable plant in certain domestic herbal markets.